Method of providing data remoteness visualisation

FIELD: medicine.

SUBSTANCE: invention relates to medical equipment, namely to equipment for visualisation of physiological data. Method of monitoring physiological parameters contains stages at which physiological parameters are measured periodically or aperiodically by at least one electronic sensor, with each measured value of physiological parameter having corresponding medical expiry date, determined and continuously visualised are: the last measured value of each measured physiological parameter and its designation, medical expiry date for each measured value of physiological parameter, which represents preliminary specified maximal time, during which value of physiological parameter is visualised, remaining medical term to expiry date of each measured value of physiological parameter for inquired time moment is determined, for each measured physiological parameter with non-zero remaining time period before expiry date determined and visualised on display are: the last measured value of physiological parameter, its designation and indication of remaining medical time period before expiry date in form of indicating the number of days, hours, minutes or seconds, during which reading is visualised, or indication of amount of time before visualisation of the following reading, with removal of reading from display in real time after preliminary configured medical term before expiry date finishes, absence of image is replaced with symbol, showing absence of current reading. Method is realised with application of machine-readable carrier, containing programme, recorded on it, and device for visualisation of data values and designations of patient's physiological parameters, which contains electronic sensors for periodical of aperiodical measurement of values of physiological parameters, processor, programmed for determination of the last measured physiological parameter and display device control.

EFFECT: application of invention makes it possible to increase rapidity of determination of data remoteness of the screen.

8 cl, 13 dwg

 

The present application relates to the technical field of display data. The present application is applicable, in particular, to displaying nonperiodically received physiological data and is described below with specific reference to the mentioned mapping. However, the application is also applicable to other types of display, in which the interest is prescription data.

Patients in a medical facility is controlled by several physiological parameters. Some parameters, such as ECG, SpO2 (blood oxygenation) and invasive blood pressure is measured continuously. Other settings type of non-invasive blood pressure, local temperature and laboratory values measured only intermittently. The values of these and other physiological parameters relevant time, as they could cause a change in treatment and are usually displayed on the monitor with date and time indicating when they were received.

Because of limitations of data parameters measured intermittently, important to the physician, these usually mark the date & time of collection of samples, in particular, the time when the measured parameter. One of the problems associated with a timestamp is that the monitor display is already overloaded numerical values of a plurality of measured physiological parameters. Another problem is t�m, the doctor decides in your mind the mathematical problem of determining how long ago, in fact, a measurement was performed. In some cases, the doctor will also determine, does, and how, the duration of the measurement on the clinical value of the measurement.

The present application provides an improved method and apparatus which solve the above-mentioned and other problems.

In accordance with one aspect, a method of displaying readings or data values. Display the reading or data value, and the display change as the value of the data becomes outdated over time, so that the mapping describes the data value and its limitations.

In accordance with one aspect, a device that displays the reading or data value. The device contains a human-readable display and a processor programmed to control the display to display indications or data values and change the displayed readings or data values or symbols gradually in time so that the displayed value or its symbol was characterized as a prescription.

Achieved the advantage of reducing congestion, in particular, the number of alphanumeric characters and symbols on the display screen.

The achieved advantage is � provide the physician the ability to quickly to determine the duration of each reading on the display screen, without mandatory physician in the mind of an arithmetic operation on the subtraction of the time when I was doing the reading, from the current time, to calculate the age of testimony, and repetition of mathematical operations for each indication on the display.

An additional advantage is to provide an intuitive evaluation of clinical significance of the display.

Other additional advantages of the present invention will be obvious to specialists with an average level of competence in the art after reading and studying the following detailed description.

The invention can be finalized in the form of the various components and layouts of components and various steps and sketches of the stages. The drawings are intended only to illustrate preferred embodiments and are not be construed as restricting the invention.

Fig. 1 image display parameters near the patient's bed;

Fig. 2 is an image illustrating the decrease in the intensity to indicate the maturity of the option;

Fig. 3 is an image illustrating the change in color to indicate the maturity of the option;

Fig. 4 - image with a subscript to indicate the maturity of the option;

Fig. 5 is an image illustrating the change in the size of the bottom of the index for specified�I ago option;

Fig. 6 is an image illustrating the gradual change of the background in the form of a circle to indicate the maturity of the option;

Fig. 7 is an image illustrating the gradual change in the background to indicate the maturity of the option;

Fig. 8 - the image with the arrows to specify hours ago option;

Fig. 9 - the image with the timer close readings of a parameter;

Fig. 10 - the image with an hourglass as a timer mechanism; and

Fig. 11 is an image illustrating the indication of the expiration date parameter readings by strikethrough.

Fig. 12 is an image illustrating the indicating that the expiration date the value has expired, by replacing the digits by three dashes.

Fig. 13 - image of the testimony together with a countdown progress bar.

As shown in Fig. 1, a medical monitor for patients using measuring devices that measure various physiological parameters, and display100that displays values of the measured parameters, usually called evidence. Mentioned testimony going electronic sensor or monitor110and displayed on the display100medical monitor, which is often located near the bed120patient. The display is some medical data in the form of graphical output130and each�x readings and information in the form of numbers 140or text150. Some of the outputs are of relevance, which depends on time. In the field of medical technology displays there is a need for a simple, intuitive means to measure and indicate the time when running the latest removal of informative readings. This application offers a number of tools by which you can measure the duration of informative statements.

In one embodiment, the implementation, the duration of the displayed data is conveyed by color or intensity data140. In another embodiment, the implementation of the prescription data is communicated in subscript next to the actual informative readings that will show the number of days, hours, minutes or seconds, during which the testimony is or may represent the amount of time until, until you will receive the following indication. In another embodiment, the implementation, the duration of display data are reported graphically160with the icon or symbol, for example, but without limitation, in the form of hours or range to be deleted sectors, hourglass or something similar. A picture or symbol represents the time interval during which data is already displayed will remain on the display, or the length of time remaining until, until you receive�about the following informative reading. The use of such tools can also reduce the congestion of the screen.

Usually, bedside monitors patients and Central monitors the nurse station displays a set of physiological parameters for each patient. Some of these parameters are measured continuously and in real time, and the other parameters measured nonperiodically. Non-periodic measurements can be performed every hour, every few hours, every day, etc. to inform carers face about how long is each display, nonperiodically the parameter to be measured, a common practice is to place a date stamp in combination with the name and numerical value of the parameter. Mark the date may be the time or time and day when the measurement was performed. Mentioned additional digits already loaded on the screen also overload them, making it difficult to read off the display. Usually, the more data is displayed, the harder it is for the user to read the display and to separate relevant data from irrelevant data. In addition, caring person must fulfil in the mind of a mathematical operation to derive the limitations of measurement based on the time when it was made.

The present application provides a method and apparatus for displaying data and �odnovremenno inform the user about how long, fresh and relevant data are in current clinical picture. The use of non-textual, intuitive method for reporting the limitations of the data, without the use of timestamps and dates removes the text from the display screen and, thereby, reduces the congestion of the screen. The relevance of the data can be specified based on the display parameter, such as brightness, intensity, color intensity associated with the designation of the parameter used to monitor real-time, using a subscript or Superscript, located on either side of the value, or special icons in the background for the informative parameter. When measure the new nonperiodically obtained, for example, non-invasive blood pressure, the parameter displays on the display by the basic display algorithm parameters. In some cases, the reading is displayed with a timestamp, and the value is automatically removed from the display of real time after the transition for pre-configured threshold ago. The threshold is a predetermined maximum time within which to display an informative parameter. An example is a data value which must remain naukrani within one hour, and after that, should be removed.

In a variant implementation, shown in Fig. 2, the medical testimony indicates the age of the displayed data by changing the intensity of the displayed digits. In the present example, the last value is the value of old, less than 15 minutes, and the last value is the most intense, brighter than all of the displayed indication210. As the outdated testimony, the intensity is attenuated so that the reading that has duration longer than 15 minutes but less than 30 minutes, namely, the display indication is indicated at220is less intense than the previously mentioned indications. Similarly, the reading of230that is older than 30 minutes but less than 45 minutes, is less intense than the previously mentioned indications, and an indication of240that has a duration longer than 45 minutes but less than 60 minutes, is less intense than the previously mentioned testimony, almost invisible. And finally, when the indication is older than 60 minutes, the display disappears completely and is replaced by a symbol indicating the absence of current evidence, for example, but without limitation, the dashed line250. The time periods provided in this case, for example, and can be applied to other intervals. �the device will function essentially, in the same way, regardless, did readings using seconds, minutes, hours, or day, etc.

In a variant implementation, shown in Fig. 3, the duration of the readings do not represent a weakening of the intensity of reference, and changes color of the countdown. The color change has the same function as the attenuation of the intensity in the above-described embodiment. So, green310might represent a prescription in less than 15 minutes, yellow320may represent age greater than 15 and less than 30 minutes, and red330can provide prescription more than 30 but less than 45 minutes, while reading old more than 60 minutes, fully display disappears and is replaced by a symbol indicating the absence of current evidence, for example, but without limitation, the dashed line340. Mentioned colours are given as a representative example, and you can assign any color to any period of time. To represent any quantitative values of time, for example, but without limitation, seconds, minutes, hours, or days, you can use any set of colors, for example, but without limitation, pastel colors, brown colors, neon colors, primary colors, etc. Color can be changed discretely or may evolve continuously. The color can be discrete or continuous�yvnym.

In one embodiment, the implementation, the displayed value of the evidence initially submitted with a maximum contrast relative to the background. As the option becomes obsolete, color or intensity weakens to the background color. For example, the color intensity is attenuated gradually to gray level. Once the threshold is reached obsolescence, informative parameter is removed.

Data display non-periodic measurements carried out in the mode intuitively perceived obsolescence. In one embodiment, the implementation, the value of meaningful readings gradually reduces your signal strength as you progress through time so that the intensity of the display data dim. In another embodiment, the implementation, the color assigned for the parameter that fades over time to a gray color. The solution replaces the time stamp or date and reduces the confusion caused by the introduction of the date and time by using auxiliary data.

As shown in Fig. 4, in another embodiment of implementation, the indication140contains subscript400. In one embodiment, the implementation, the subscripts denote the nominal term use of non-recurrent result of measurement in which mentioned the result of obsolete. Given the importance of the testimony may fade or alter CEE�, as explained above. In this case, the presence of a 1 in the lower index means that the indication is valid for 1 hour, as indicated by the position of the410. Subscript 8 indicates that the reading is valid for 8 hours, as indicated by the position of the420. Subscript 12 indicates that the reading is valid for 12 hours, as indicated by the position of the430. Subscript 24 indicates that the reading is valid for 24 hours, as indicated by the position of the440. And finally, when the indication is older than 24 hours, the display disappears completely and is replaced by a symbol indicating the absence of current evidence, for example, but without limitation, the dashed line450. Given the time periods are approximate, and, in your device, you can use other time intervals. The device will function essentially the same way, regardless, did readings using seconds, minutes, hours, or day, etc. In another variant implementation, the subscripts are used to identify obsolescence or the remaining period of use.

As shown in Fig. 5, the lower index indicates the prescription represents the values of the readings on the display. Prescription indications may also be represented in the size or shape of the lower index, while the lower index is the largest for novog� evidence as in the position of510and decreases to a smaller size, as in the positions of520530540that as reading becomes obsolete, or becomes more sloping or less fat as time passes. And finally, when the indication is older than 24 hours, the display disappears completely and is replaced by a symbol indicating the absence of current evidence, for example, but without limitation, the dashed line550.

Fig. 6 shows another embodiment of the display limitations of the informative parameter. The display may include, but without limitation, the terms600where is the value of602data. Prescription shown the readings are reported using the graphical symbol. In one embodiment, the implementation of the reading that is new or has age just a few minutes, is displayed on the background of a full circle, as in the position of610. After a short period of time, for example, but without limitation, 7-10 minutes from the circle is cut out a small section, as in the position of620. As time passes, for example, or through, approximately 15 minutes, the sector is increasing up to a quarter of a circle, as in the position of630. Similarly, as a further indication obsolete 22-25 minutes, the sector continues to grow in size, as in b> 640. Like arrows hours, 30 minutes mark disappears half of the background, as in the position of650. When the duration exceeds 30 minutes, there is an additional circle removal, and the background is minimized, as in the position of660. At time 45 minutes outdated, missing three-fourths of the background, as in the position of670. And finally, when the prescription will exceed 45 minutes, there is only a small part of the circle, as in the position of680. Value and the circle will disappear completely after 60 minutes, as in the position of690. Thus, the pictogram sector simulates the movement of the clock hands.

Fig. 7 shows another embodiment of the display limitations of the informative parameter. The display may include, but without limitation, the frame700where is the value of702data of the second color. Prescription shown the readings are reported using the graphical symbol. In one embodiment, the implementation of the reading that is new or has age just a few minutes, appears on the full background as to the position of710. After a short time, for example, but without limitation, 7-10 minutes, removed a small sector, as in the position of720. As time passes, for example, or through, approximately 15 minutes, the sector had increased to a quarter, as in the position of730. Similarly, �about, as the outdated testimony in addition to 22-25 minutes, the sector continues to grow in size, as shown at position740. Like arrows hours, 30 minutes mark disappears half of the background, as in the position of750. When the duration exceeds 30 minutes, runs more removal, and the background is minimized, as in the position of760. At time 45 minutes outdated, missing three-fourths of the background, as in the position of770. And finally, when the prescription will exceed 45 minutes, it only remains a small sector as at position 780. Value and the frame will disappear completely after 60 minutes, as in the position of790. Thus, the pictogram sector simulates the movement of the clock hands.

Fig. 8 shows an additional variant of implementation of the present application, which also apply icons800hours. In another embodiment of the hours810use the arrow820hours behind830testimony. Furthermore, in another proposed interface840you can use the watch with the two arrows for tracking minutes850and hours860located behind the description indications or measured value870.

Fig. 9 shows an additional variant of the implementation of the900to display the old testimony. In one embodiment, the implementation of910the prescription920display�is about designations indications or measured value 930. Furthermore, in another embodiment of the proposed940the prescription display using as hours, minutes hours using950with two down arrows approximately indicate indications or measured value960.

As shown in Fig. 10, an additional variant of the implementation of the1000provides another display1010for intuitive perception of time, for example, but without limitation, hourglass1020indicating the limitations of the data readings. In the present embodiment, hourglass1020there are about displaying1030testimony. Hourglass1040contain the upper segment of the1050and the bottom segment of the1060. When the informative value of the evidence is new, the top end of the1050darkened, and the bottom segment of the1060transparent. As the outdated testimony, as shown at position1070the upper segment is reduced in volume, and the bottom segment is increased in volume, essentially this volume, which decreased from the upper segment. Once the meter reaches the end of its validity, as in the position of1080the volume of the upper segment of the1080is empty, and the volume of the lower segment of the1090essentially equal to the original upper level of the initial segment of1050. The display works essentially the same way regardless did readings using seconds, minutes, hours, or day, etc. the Hourglass can be displayed behind the statement.

As shown in Fig. 11, another embodiment of the1100the present application contains display icons to indicate that the shelf life of the non-recurrent result of measurement has expired. The icons contain, but without limitation, a slash, a symbol of1110"no", consisting of a frame or circle1110with a slash1130superimposed on top of the displayed value of1120testimony, or the symbol "X"1140on top of the1150testimony. In addition, you can also opt out of displaying the measurement time. It is also anticipated the use of pictograms, which hold the designation to indicate that the measurement should be in this place, instead of the simple removal of the designation or the value. As shown value, and pictographic symbol value can be the same color or different colors, in this case, the value may be darker or lighter than pictographic symbol.

In addition, the pointers presented in this case, contain change of intensity in the loosening direction, the change of color, the use of a subscript or background change. To specify the old testimony inform�tive option can be combined in any way other change graphic symbols.

As shown in Fig. 12, outdated value can be shown by substituting the numeric value or alphanumeric characters by a dotted line. The value is submitted before the expiration of its shelf life, as indicated by the position of the1210and thus, the indication is communicated to the user. Once the meter is no longer suitable, the digital component of the indications may be replaced by a dashed line1220. In another embodiment, implementation is also possible substitution of alphanumeric characters that describe the indication1230for example, "HR", in addition to the replacement of the displayed values, so that all the space originally occupied by indication, entirely replaced by dashes, as soon as the value is considered expired.

As shown in Fig. 13, you can also apply a range of countdown messages for the duration of the testimony. In this embodiment, the new alphanumeric medical indication1310will be accompanied by a graphic line1320located above, below or beside the values of the medical evidence. The line can be completely darkened to indicate that the medical value is new, and may undergo a transition consisting in the removal of darkening the darker area over time and the obsolescence of medical values. The designation1330lying�nor can be, essentially, about graphic line.

As time passes and outdated medical value, as indicated by the position of the1340the line can undergo the transition from a fully shaded graphical display1320to partially obscured, a graphic display1350. The amount of time that has passed or remains from the length of service of medical values, you can determine with the help of the accompanying designation of1360. The degree to which darkened the display will perfectly match the period of time that has passed since it was originally formed medical value.

At the end of the period of use of medical1370the line can be completely devoid of shade so that it not be a shadow, or the darker area within the remaining circuit previously dark or shadow line1380. Referred to line without shading or dimming can also be with the accompanying designation of the1390.

In alternative implementation, the graphical ruler may be, in the beginning of the term of use, completely UN-shaded or unshaded, which should indicate that the contemporaneous medical value is new. In the present version of the implementation, graphic line will�tapeno thus to fade or be filled to the extent that as time passes, and medical value becomes obsolete, so that is partially shaded or darkened line will denote aging medical value. At the end of the period of use of medical significance, graphic line can be completely darkened and, thus, to indicate that the period of use of medical value has expired, and the said value is obsolete.

In an additional embodiment, the implementation, shading or darkening can be replaced by changing the color, color hue, color intensity, structure or form of shading graphic line. Color change or darkening may occur from right to left, left to right, from the center out to the edge, from the edge inward to the center, top to bottom, bottom to top, from inside to outside, outside to inside, diagonally from top right corner to the bottom left corner, diagonally from upper left to lower right corner, diagonally from the bottom right corner to the upper left corner, diagonally from lower left to upper right, etc.

Method, system and device described in the present application may also contain computer-controlled means, including, but without limitation, computer data entry tool, a computer terminal for data representation, computer memory, which may contain a database, and network �the connection, which can ensure the interaction method, system and device in the computer network system, including, but without limitation, the Internet.

Description of the invention given with reference to preferred options for implementation. Experts can create modified and make changes after reading and studying the above detailed description. It is assumed that the invention should be interpreted as containing all of the mentioned modifications and changes to such extent that they are within the scope of the claims appended claims or their equivalents.

1. Method of monitoring physiological parameters, comprising stages on which:
is measured periodically or aperiodically physiological parameters of at least one electronic sensor, wherein each measured value of the physiological parameter has a corresponding medical the expiration date;
determine, by the processor, and continuously display on the display:
the last measured value for each measured physiological parameter and symbol,
medical the expiration date for each measured physiological parameter values, which are displayed together with the corresponding value of the physiological parameter and which is a pre�about the specified maximum time, during which displays the value of the physiological parameter,
determine the remaining medical expiry date of each measured value of the physiological parameter at the requested time,
for each measured physiological parameter with non-zero remaining shelf life to determine and display on the display the last measured value of the physiological parameter, symbol and indication of remaining medical expiry date showing the number of days, hours, minutes or seconds, during which the indication is displayed, or specify the amount of time until you will receive the following testimony, and
remove the indication from the display in real time after the expiration of the pre-configured medical expiration date,
replace the missing image symbol indicating the absence of current evidence.

2. A method according to claim 1, containing an indication of the remaining medical shelf life measured health parameter includes at least one of:
the formation instructions to change the icons in accordance with a remaining medical expiry date;
forming instructions for subscript or Superscript, located on either side of the value, or icons in the form of background info for�rmativnogo option indicating the remaining medical the expiration date.

3. A method according to any one of claim 1 or 2, containing a formation instruction for forming and changing icons, includes imitation clock functions(600, 700, 800).

4. A method according to claim 3 containing imitation watches, including the formation of instructions to display:
of a circle or rectangle, divided into sectors (600, 700), which gradually change color similar to the arrow hours; or
circle with arrow hours (820), which moves with time.

5. A method according to any one of claims. 1, 2, 4, in which a formation instruction for forming the pictogram contains the formation of one of the icons (900) hours or icons (1010) hourglass related with the value or symbol.

6. A method according to claim 1, which contains the measurement of the physiological parameter by measuring intermittently physiological parameter of the patient.

7. Machine-readable media containing recorded therein a program which when executed by a processor causes a computer to execute the steps of the method according to claim 1.

8. A device for displaying data values and signs of physiological parameters of a patient that contains:
electronic sensors for periodic or aperiodic measurement values of physiological parameters, and measured values are ACC�relevant medical expiry date;
a processor programmed to:
determine the most recent measured physiological parameter and denote for each display value,
control display device;
determine the time that indicates the remaining shelf life of each displayed value, and
for each measured physiological parameter with non-zero remaining shelf-life of excretion of the latest measured values, symbols and indication (specify) remaining medical expiry date showing the number of days, hours, minutes or seconds, during which the indication is displayed, or an indication of the amount of time until you will receive the following testimony, and removal of the readings in real time after the expiration of the pre-configured medical expiry date.



 

Same patents:

FIELD: physics, control.

SUBSTANCE: invention relates to computer engineering. A climate control device, having a network interface configured to receive a request to use the climate control device; transmit an authorisation request to a payment system in response to receiving said request; receive an activation message containing information associated with the payment system in response to the authorisation request; transmit a payment message to the payment system based on a plurality of usage parameters, wherein the payment message leads to the deduction of funds from the account of the user; a user interface configured to receive user input which identifies a climate control programme containing a temperature parameter, a humidity parameter, an ionisation parameter, a dryer parameter, an air purification parameter, a sound parameter and a fragrance parameter, wherein each of said parameters is associated with a corresponding one of a plurality of times, a plurality of durations and a plurality of set values; and a climate control subsystem configured to change the environment based on the climate control programme.

EFFECT: automated climate control on a confined territory.

13 cl, 1 tbl, 11 dwg

FIELD: measurement equipment.

SUBSTANCE: invention relates to methods for determining variation of a valve parameter for valve control. According to a diagnostic method of a control valve, data on position, which indicates position of the control valve, and data on pressure, which indicates pressure drop on the valve actuator, and unnecessarily direction of stroke of the control valve is measured (41) during online operation of the control valve. Data on position and data on pressure drop is processed (42) so that it can contain data near initial points of a variety of individual movements of stroke of the control valve during normal online operation of the control valve. Finally, a chart of variation of the valve parameter of the control valve is determined (44) based on processed data on position and on pressure drop, which are collected in the variety of points along the stroke range of the control valve during online operation of the control valve.

EFFECT: improvement of accurate diagnostics of valves in online modes.

16 cl, 10 dwg

FIELD: transport.

SUBSTANCE: invention relates to method for vehicle tire pressure determination. The method includes monitoring system starting in learning mode, timer stating if vehicle speed has exceeded preset threshold, timer stopping if speed is less than or equal to speed threshold or if preset time period has elapsed, readout of several pressure values in different tires during timer operation, saving these values in memory and their averaging to determine recommended pressure threshold after preset time period has elapsed, as well as setting recommended pressure threshold in tire pressure monitoring system.

EFFECT: possibility to determine low tire pressure and to monitor tire pressure.

11 cl, 3 dwg

FIELD: radio engineering, communication.

SUBSTANCE: device includes an input data setting unit, eight multipliers, four adders, two dividers, two square root calculation devices and a subtraction device; the following new units are introduced: eight multipliers, two dividers, two subtraction devices, two square root calculation devices, two sine calculation devices, as well as two additional outputs of the input data setting unit, communications between the specified units and other elements of the device.

EFFECT: improving target detection accuracy.

3 dwg

FIELD: medicine.

SUBSTANCE: group of inventions refers to medicine. A drug delivery control unit comprises a user's interface configured to receive input data. The input data comprises patient's data and/or drug data and/or vascular access device data. A sensor is configured to measure a liquid pressure rate in a liquid delivery canal, which is used to deliver the drug to a patient's infusion site by means of the vascular access device. A processor is configured to assess a model state of the infusion site on the basis of the pressure rate in the liquid delivery canal and the input data. An output device notifies, supplies an urgent signal and/or a graphic/digital indication if the assessed model state of the infusion site and the liquid pressure rate in the liquid delivery canal to the infusion site testifies to infiltration. There are disclosed a method for controlling the drug delivery and a computer-readable carrier containing commands for implementing the method.

EFFECT: inventions enable detecting the infiltration condition and notify about the same.

16 cl, 6 dwg, 1 tbl

FIELD: medicine.

SUBSTANCE: group of inventions refers to medicine, namely to organising and conducting insulin therapy for a patient. Determining a user's dose of basal insulin is ensured by using a device for insulin administration and a portable device for diabetic data control. The method involves measuring the number of the user's blood glucose concentrations over the number of time intervals. The collected data are used to state if the user has performed the minimum number of measurements of the fasting blood glucose concentration over at least one of the four time intervals prescribed. That is followed by stating if the collected data indicate one of the first schedule showing the low blood glucose concentration, and the second schedule showing the lower blood glucose concentration than in the first schedule showing the low glucose concentration. Thereafter, the method provides considering if the basal insulin dose correction in the portable device for the first and second schedules correspond to each other; the user is warned, and the basal insulin dose correction is prohibited in any of the devices. Taking preventive measures aiming at measuring the basal insulin dose by means of the devices involves collecting the data, and the preventive measures are taken to avoid the user's hypoglycaemic state.

EFFECT: group of inventions enables rendering aid in the patients suffering from diabetes by means of the devices for determining the basal insulin dose and controlling the blood dose level in an insulin dose and taking the preventive measures.

27 cl, 11 dwg

FIELD: measurement equipment.

SUBSTANCE: method allows visualising controlled parameters of an object, work progress of the object and prompt formation. In addition to the visualisation unit of controlled parameters and storage units of scheduled, actual and archive charts of operations on the object, the system includes shaping elements of control and informative messages.

EFFECT: improving promptness of decision making at deviations from a normal progress of operations on the object.

18 cl, 4 dwg

FIELD: medicine.

SUBSTANCE: invention relates to means for the estimation of energy efficiency of a cardiovascular system. The method of automatic processing of blood pressure signals contains stages at which: a detected pressure signal P(t) for one or more heart contractions is discretised, with each heart contraction starting at an initial moment, coinciding with the moment of the diastolic pressure, and finishing at the last moment, coinciding with the moment of the following diastolic pressure, and containing a dicrotic point, the morphology of a discretised pressure signal P(t) for each heart contraction is analysed and separated, the moment and value of pressure in one or more characteristic points of the signal P(t) are determined. For each heart contraction a value of energy efficiency is determined by the determination of the impedance Zd-D(t) of a direct dynamic wave of pressure for each of one or more characteristic points, except the point of an initial diastolic pressure, and the impedance ZD of a direct pressure wave is determined by the addition with alternating signs of values of the impedances Zd-D(t) of the direct dynamic pressure wave, ordered in accordance with the direct time order, starting with the initial moment of the analysed heart contraction, to a dicrotic moment, the dynamic reflected impedance Zd_R(t) is determined for each of one or more characteristic points and the value of impedance ZR of reflected pressure waves is determined, energy efficiency is determined as a ratio between the impedance ZD of the direct pressure wave and the impedance ZR of the reflected waves RES=ZD/ZR. The method is realised by an automatic device for processing the blood pressure signal with the application of a storage medium, which contains stored software.

EFFECT: application of the invention makes it possible to increase the reliability of energy efficiency estimation.

14 cl, 6 dwg

FIELD: medicine.

SUBSTANCE: invention relates to means for glucose level control. The method of presenting information about the analyte concentration consists in the following: a value of concentration of at least one analyte, present in each of a multitude of physiological samples, taken during the first preliminarily determined time interval, is measured by means of an analyte sensor, the values of the analyte concentration are stored, the accordance of the quantity of the stored values of the analyte concentration to the minimal threshold value is determined, current measurement of the analyte concentration is presented simultaneously with at least one of the two selected headlines of the message, containing an overview of the stored values of the analyte concentration for the preliminarily determined time interval or a model of tendency in the change of the stored values of the analyte concentration, and the message is demonstrated after the selection of a message headline for the model of change tendency for the second preliminarily determined time interval. The second version of the method includes an additional notification by the message after the selection of the heading for an overview of the stored values of the analyte concentration, showing the distribution of values for one of the preliminarily determined ranges, the first threshold or the second threshold, exceeding the first threshold values. The third version includes the estimation, after the determination of the correspondence of the quantity of measurements to the minimal threshold value, of the correspondence of the stored values of the analyte concentration to one or several rules, preliminarily stored in a measuring device, in order to form the message, which contains some of the stored values as a part of the message, sent to the user, with the presentation of the current analyte measurement and simultaneous demonstration of the message to the user as the first message, received by the user before receiving any other messages. In the fourth version of the method implementation, after the determination of the accordance of the quantity of measurements to the minimal threshold value, estimated is the correspondence of the stored values of the analyte concentration to one or several rules, preliminarily stored in the measuring device, in order to form the message, which contains some of the stored values as a part of the message, sent to the user, with the presentation of the current measurement of the analyte concentration from the measurement stage and simultaneous demonstration of the message to the user after the measurement stage. In the fifth version the tendency of change of glucose concentration values towards a decrease, identified on a particular day, in which at least one value of the glucose concentration is lower than the second preliminarily determined threshold on each of the three last days is additionally automatically identified for the particular day, the tendency of change of the glucose concentration values towards an increase, identified on a particular day, on which at least one value of the glucose concentration is higher than the first preliminarily determined threshold on one of the three last days within one and the same time interval, with sending to the user a multitude of dates, on each of which there is only one corresponding message, with such a corresponding message containing data about either the tendency of change of the values towards the increase or the tendency of change of the values towards the decrease, and if on one particular date both tendencies are identified, the user is informed only about the tendency of change of the values towards the decrease.

EFFECT: application of the invention makes it possible to simplify control and increase the accuracy of measuring the glucose level in blood.

18 cl, 8 dwg

FIELD: weapons and ammunition.

SUBSTANCE: complex comprises an electronic computer, data transfer equipment with communications means, automation means, interface unit of operational and tactical and radar information, which is connected to the switching device of connection and two data transfer instruments with communications means. One of the instruments is designed for information exchange of radar information with the reconnaissance asset, and the other - for information exchange of operational and tactical information with superior, subordinate and interacting control bodies. The interface unit comprises a control unit which enables to handle radar information from the reconnaissance assets at that the ability to process in it the operational and tactical information coming from the superior, subordinate and interacting control bodies is maintained. For the target accepted for destruction the complex provides an opportunity to detect the proofs of shooting settings and data of flight mission to serve the shooting in real time.

EFFECT: increased efficiency of target destruction by giving rocket formations and formations of multiple artillery rocket systems of heavy calibre the properties of reconnaissance-strike complex operating on the principle of reconnoitred-struck.

1 dwg

FIELD: medicine.

SUBSTANCE: "orthopaedic index" is calculated as a sum of three values. The first value is derived by conducting densitometry, and points are assigned according to its findings: 1 point for norm, 2 points for osteopenia, 3 points for osteoporosis, and 4 points for severe osteoporosis. The second value is derived by means of Charlson comorbidity index; 0-2 points according to the Charlson comorbidity index scale correspond to 1 point of the second value; 3 points of the Charlson comorbidity index scale are 2 points of the second value; 4 points of the Charlson comorbidity index scale show 3 points of the second value, while 5 points and more of the Charlson comorbidity index scale correspond to 4 points of the second value. The third value is determined by assessing the quality of life as per the scales SF-36; 0-200 points according to the scales SF-36 correspond to 4 points of the third value; 201-400 points of the scale SF-36 show 3 points of the third value; 401-600 points of the scales SF-36 provide 2 points of the third value, and 601-800 points correspond to 1 point of the third value. Total score is deriving by summing up the three values to determine "the orthopaedic index": I - 1-3 points, II - 4-6 points, III - 7-9 points, IV - 10-12 points. The form of treatment is defined: the patients with index I have the endoprosthesis replacement with endoprostheses with a shortened leg of the femoral component, the greater diameter of the head (36 mm or more); the patients with index II have the endoprosthesis replacement with cementless anchored total endoprostheses; the patients with index III have the total hip replacement with cemented endoprostheses; the patients with index IV have the endoprosthesis replacement with cemented anchored bipolar endoprostheses.

EFFECT: through assessing the available factors influencing the postoperative period, prosthesis anchoring in its bed, potential endoprosthesis rejection, functional effect and potential aggravation of comorbidities, the method can improve functional outcomes, reduce the risk of endoprosthesis loosening and the risk of recurrent operations.

2 ex

FIELD: medicine.

SUBSTANCE: invention relates to devices for medical monitoring. The method contains stages at which: a packet (7) of data about a patient is transmitted from a device (10) for patient monitoring to the central server (12); a message (72) with acknowledgement (ACK), transmitted by the central server (12) in response to receiving by the central server (10) of the transmitted packet (70) of data about the patient, with a message with acknowledgement containing a time stamp, provided from the central server (12) clock (46), indicating the time and date, when the central server (12) received the packet (70) of the patient's data; the message time stamp (72) with ACK is compared with the current time of the clock (28) of the patient monitoring device (10); and if the difference between the current time of the clock (28) of the patient monitoring device (10) and the time stamp (74) with ACK is larger than the first preliminarily determined time, the clock (28) is synchronised in accordance with the time and date in the time stamp (74) in the message (72) with ACK.

EFFECT: provision of control of the time synchronisation interface.

13 cl, 5 dwg

FIELD: medicine.

SUBSTANCE: non-invasive examination of vessels is performed by means of a probe, installed on the skin surface in the projection of a vessel, by a method of optic coherent (OC) tomography, tomograms, obtained without compression test and OC tomograms under conditions of the compression test by the displacement of tissues by the probe by 1 mm towards the visualised vessel, are analysed. Compressibility of the vessel, tissues and formations and uniformity of the vessel configuration change under compression are estimated on the images. If a non-uniform and/or incomplete compressibility and a non-uniformity of the vessel configuration change are detected, microangiopathy is identified.

EFFECT: method ensures the high accuracy and objectivity of non-invasive diagnostics of the condition of microvasculature, in particular, the presence of intra-vascular formations, including differential diagnostics of vasculopathy due to the identification of particular criteria for the determination of pathological changes.

5 dwg, 4 ex

FIELD: chemistry.

SUBSTANCE: group of inventions relates to surface hydrophilisation and immobilisation of antibodies on the surface of a cycloolefin copolymer. Disclosed method of making a capillary-action analytical device, which includes steps of: a) providing a capillary substrate, b) changing the hydrophilic property of the surface, c) mixing a matrix and immobilised molecules in solution form to obtain a solution which includes immobilised molecules covalently bonded to the matrix, and d) depositing the solution on a well defined region in at least one storage area. Also a capillary-action analytical device made using said method is described.

EFFECT: enabling change of the substrate by chemical treatment of the surface and depositing immobilised molecules in an optimum matrix on given regions, with less consumption of matrix material, which enables to use several different matrix material in the same chip.

33 cl, 3 dwg

FIELD: medicine.

SUBSTANCE: invention relates to medical working process of visualisation. System contains: control unit (114), containing processor (116); and multitude of processing executives (102), connected with it, with processor (116) realising control of realisation with feedback of plane of medical visualisation working process by means of multitude of processing executives (102), and processor (116) is made with possibility of inquiring electronic medical information, dealing with and/or not dealing with visualisation from one or more processing executives; formation of plan of visualisation procedure working process by means of visualisation procedure, based on information inquired; reception of signal, indicating due date of planned visualisation procedure; downloading visualisation protocol, corresponding to visualisation procedure, into visualisation system, used for visualisation procedure; realisation of scanning by means of visualisation system; and updating plan of visualisation procedure working process.

EFFECT: increased reliability of patient diagnostics.

15 cl, 9 dwg

FIELD: medicine.

SUBSTANCE: clinical research aimed at detection arterial hypertension is performed. Echocardiographic examination with the detection of signs of sclerogenic changes of the aorta is carried out. A value of function F is calculated. 2 demographic parameters - sex and age are taken into account, 1 clinical parameter is arterial hypertension and 1 echocardiographic parameter - presence of the sclerogenic injury of the aorta. Then the value of a probability level P is calculated. Patients with unchanged coronary arteries have the value P lower or equal 0.204. In patients with non-obstructive coronary-sclerosis it is over 0.204.

EFFECT: method makes it possible to exactly, at early stages of the disease, carry out non-invasive diagnostics, determine indications for effective treatment actions, ensures the prevention of complications due to the application of available clinical and instrumental methods, including in calculation most significant clinical signs, application of methods of determining the probability of the presence of non-obstructive coronary-sclerosis.

2 dwg, 2 tbl, 1 ex

FIELD: medicine.

SUBSTANCE: blood pressure is measured according to the standard procedure on the brachial artery by means of the Riva Rocci Korotkoff sphygmomanometer. The vegetative status is assessed by the rest heart rate variability parameters. The endothelial vasomotor function is described as a percentage measure of a resistance index after inhalation of Salbutamol 400 mcg, an endothelium-dependent vasodilator as related to a basal resistance index by photoplethysmography. The derived data are used to determine an adequate basal pulse wave velocity and a pulse wave velocity following the sublingual administration of nitroglycerin 500 mcg, for each patient individually by original formulas.

EFFECT: method enables providing the more accurate determination of the adequate basal pulse wave velocities and the pulse wave velocity following the administration of nitroglycerin taking into account the vegetative status.

2 dwg, 1 tbl, 1 ex

FIELD: medicine.

SUBSTANCE: group of inventions refers to medicine, namely to organising and conducting insulin therapy for a patient. Determining a user's dose of basal insulin is ensured by using a device for insulin administration and a portable device for diabetic data control. The method involves measuring the number of the user's blood glucose concentrations over the number of time intervals. The collected data are used to state if the user has performed the minimum number of measurements of the fasting blood glucose concentration over at least one of the four time intervals prescribed. That is followed by stating if the collected data indicate one of the first schedule showing the low blood glucose concentration, and the second schedule showing the lower blood glucose concentration than in the first schedule showing the low glucose concentration. Thereafter, the method provides considering if the basal insulin dose correction in the portable device for the first and second schedules correspond to each other; the user is warned, and the basal insulin dose correction is prohibited in any of the devices. Taking preventive measures aiming at measuring the basal insulin dose by means of the devices involves collecting the data, and the preventive measures are taken to avoid the user's hypoglycaemic state.

EFFECT: group of inventions enables rendering aid in the patients suffering from diabetes by means of the devices for determining the basal insulin dose and controlling the blood dose level in an insulin dose and taking the preventive measures.

27 cl, 11 dwg

FIELD: medicine.

SUBSTANCE: neurovisualisation examination of brain is carried out, Cirs comorbidity index and Kaplan-Feinstein comorbidity index are determined, cochleovestibular syndrome, eye-moving impairments, type of diabetes mellitus are identified. Value of discriminate function (D) is calculated. If D value is higher than zero, diagnosed are consequences of ischemic brain stroke (IBS) with hyperhomocysteinemia (HH), if D is lower than zero, consequences of IBS without HH are diagnosed.

EFFECT: method makes it possible to increase reliability of diagnostics of IBS consequences, which is achieved due to complex analysis of said parameters.

2 ex

FIELD: medicine.

SUBSTANCE: invention relates to control of sugar level in blood. Method contains the following stages: multitude of measurements of glucose level in user's blood is carried out by means of microprocessor; multitude of measurements of glucose level in blood is stored in memory device; it is determined whether the last measurement of glucose level in blood, performed at specified moment of time during the day, is lower than the first threshold, which constitutes about 70 mg of glucose per decilitre of blood, or higher than the second threshold, which constitutes about 150 ml of glucose per decilitre of blood; it is estimated by means of microprocessor if, at least, one measurement of glucose level from multitude of measurements, carried out in time interval approximately 3-hour long relative to specified time, at which the last measurement of glucose level in blood for previous days, was lower the first threshold or higher than second threshold; it is notified that for the same time period for previous days multitude of measurements of glucose level in blood shows the tendency of reduction of glucose level in blood relative to the first threshold or of increase of glucose layer relative to the second threshold.

EFFECT: increased accuracy of determination of user's state for control of diabetes course.

24 cl, 17 dwg

FIELD: medicine.

SUBSTANCE: method involves carrying out ultrasonic scanning examination of subclavian artery over its whole extent in physiological arm position with arterial blood pressure being measured in the middle one third of the arm. Next, when applying compression tests, blood circulation parameters variations are recorded in distal segment of the subclavian artery with arterial blood pressure being concurrently measured. Three degrees of superior thorax aperture syndrome severity are diagnosed depending on reduction of linear blood circulation velocity and arterial blood pressure compared to their initial values. Mild one takes place when linear blood circulation velocity reduction reaches 40% and arterial blood pressure 20% of initial level, moderate one when linear blood circulation velocity reduction reaches 70% and arterial blood pressure 50% and heavy one when linear blood circulation velocity reduction is greater than 70% of initial level and arterial blood pressure is greater than 50% to the extent of no blood circulation manifestation being observed in the subclavian artery.

EFFECT: high accuracy of diagnosis.

Up!